Aspirin therapy in diabetes is underutilized

被引:9
作者
Colwell, JA [1 ]
机构
[1] Med Univ S Carolina, Ctr Diabet, Charleston, SC 29425 USA
关键词
D O I
10.2337/diacare.24.2.195
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:195 / 196
页数:2
相关论文
共 13 条
[1]
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]
Aspirin therapy in diabetes [J].
不详 .
DIABETES CARE, 1997, 20 (11) :1772-1773
[3]
DIMINNO G, 1986, BLOOD, V68, P886
[4]
FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292
[5]
Diabetes and decline in heart disease mortality in US adults [J].
Gu, K ;
Cowie, CC ;
Harris, MI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (14) :1291-1297
[6]
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[7]
HALUSHKA PV, 1981, J LAB CLIN MED, V97, P87
[8]
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[9]
RELEASE OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN WHOLE-BLOOD IS INCREASED IN PATIENTS WITH TYPE-II DIABETES [J].
JOKI, R ;
KLEIN, RL ;
LOPESVIRELLA, MF ;
COLWELL, JA .
DIABETES CARE, 1995, 18 (08) :1150-1155
[10]
A PROSPECTIVE-STUDY OF ASPIRIN USE AND PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE IN WOMEN [J].
MANSON, JE ;
STAMPFER, MJ ;
COLDITZ, GA ;
WILLETT, WC ;
ROSNER, B ;
SPEIZER, FE ;
HENNEKENS, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (04) :521-527